CorVista Health Announces New AMA Category III CPT® Code for Augmentative AI Analysis of Cardiopulmonary Disease
CorVista Health, has announced that the American Medical Association (AMA) has granted a new Category III Current Procedural Terminology (CPT®) code for novel augmentative AI algorithmic analysis of potential coronary artery disease (CAD), pulmonary hypertension (PH), and elevated pulmonary capillary wedge pressure (PCWP). The new code encompasses the FDA-cleared CorVista® System for CAD and PH, as well as the anticipated PCWP Add-On algorithm which is currently under FDA review and not commercially available in the United States.
CPT codes are used by physicians, hospitals, and public and private health insurance programs in the United States to identify medical services and procedures. Category III CPT codes are temporary codes assigned to emerging technologies, services, and procedures, and are commonly used to support data collection, utilization tracking, and the development of future reimbursement pathways.
The new Category III CPT code, 1104T, will become effective Jan. 1, 2027, and will support reporting for the use of the CorVista System in the assessment of potential CAD, PH, and elevated PCWP using augmentative algorithmic analysis of orthogonal voltage gradient and photoplethysmography signals. The code represents an important milestone in CorVista’s reimbursement strategy and supports broader adoption of its point-of-care technology across cardiovascular care settings.
